PRISM MediaWire

BranchOut Food Prices $1.4 Million Follow-On Public Offering

BEND, Ore., June 26, 2024 - PRISM MediaWire - BranchOut Food Inc. (NASDAQ: BOF) (“BranchOut” or the “Company”), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the pricing of its underwritten public offerin...

27 June 2024

BranchOut Food Ships First Production of New, Innovative Products to Nation’s Largest Retailer, Initiating Second of Three Existing Contracts Totaling $8M

BranchOut Food contracts with the retailer now total approximately $8 million in annualized revenue

26 June 2024

BranchOut Food Enters the $300 Billion Industrial Food Ingredients Market

Industrial food ingredients expected to be a valuable additional commercialization channel

25 June 2024

SKYX Announces Issuance of 6 Additional Patents in the U.S. and Globally including China, India, Europe, Canada, and Mexico for its Advanced Smart Plug & Play Ceiling Fan & Heater

SKYX’s Enhances its Robust Patent Portfolio Now Totaling over 94 Issued and Pending Patents with over 36 Issued Patents in the U.S. and Globally

24 June 2024

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

Cinnamon Churro Banana Bites and Chili Lime Pineapple Chips—Both Made with GentleDry Technology—Excelled in Recent Shelf Life and Sensory Tests

24 June 2024

Oncocyte Appoints Andrea James as Chief Financial Officer

IRVINE, CA, June 17, 2024 - PRISM MediaWire - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea James, to the position of Chief Financial Officer.

17 June 2024

BranchOut Food Inc. Secures Fourth EnWave Dehydration Machine for New Peru Factory with $40M Production Capacity

BEND, Ore., June 17, 2024 - PRISM MediaWire - BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced it has signed a purchase agreement for a 10kW Radiant Energy Vacuum (REV) mac...

17 June 2024

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Clinical testing of LP-310 expected to commence in mid-2024

31 May 2024

AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

HAUPPAUGE, NY, May 30, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5...

30 May 2024

Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Abstract highlighting new preclinical data from LP-50 in non-muscle invasive bladder cancer

29 May 2024